carbachol has been researched along with Kidney Diseases in 2 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Gowilly, SM | 1 |
| Tomiak, RH | 1 |
| Barlow, RB | 1 |
| Smith, PJ | 1 |
2 other studies available for carbachol and Kidney Diseases
| Article | Year |
|---|---|
Metoprolol ameliorates cyclosporine a-induced hypertension and nephrotoxicity in rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Antioxidants; Blood Pressure; Carbachol; Cyclospori | 2011 |
Are there valid reasons for using anti-muscarinic drugs in the management of renal colic?
Topics: Barium; Barium Compounds; Carbachol; Chlorides; Colic; Dose-Response Relationship, Drug; Female; Hum | 1985 |